TL;DR: OKRs for R&D teams fail when you score them the way you’d score a delivery team. Research outcomes are uncertain by definition, so outcome-anchored KRs either kill the exploration (people pick safe targets) or get retrofitted at the end of the quarter (everyone discovers they hit 0.7). The fix is to score delivery work against outcomes and research work against the rigor of the inquiry. This post is the playbook for writing KRs that hold up under both conditions.
Your research team got handed the company OKR template last quarter. The first KRs came back, and something felt off. Half the team had committed to safe outcomes they’d already half-completed. The other half had committed to research outcomes nobody could honestly predict. By week six it was clear the cycle was going to end in awkward QBR conversations about what “success” actually meant. The team isn’t bad at OKRs. OKRs for R&D teams break this way because the standard rubric was built for delivery work, and you’re running a function whose entire job is to figure out what’s possible.
This isn’t the foundational guide on how to write OKRs. That post covers the craft for any team. This is the deep dive on what to do when the team can’t reliably predict the outcome of the work, because the work is the act of finding out.
What’s actually different about OKRs for R&D teams? OKRs for R&D teams have to measure the quality of the inquiry, not just the outcome of it. Delivery teams know what they’re shipping and can commit to an outcome target. R&D teams are running experiments to figure out whether something is possible, and the honest answer might be no. A scoring system that treats those two situations the same will distort one of them.
Why OKRs for R&D Teams Get Gamed
When a research team is handed the standard OKR template, two things happen, usually at the same time.
The first is safe-bet bias. The team learns that KRs get scored on a 0 to 1 scale, that 0.7 is roughly “good,” and that anything under 0.5 invites questions in the QBR. So they pick KRs they already know they can hit. The adaptive deception research becomes “publish two whitepapers.” The new sensor architecture becomes “ship the prototype.” The whole reason the org funds a research function, to explore things nobody else has, quietly stops happening. The KRs are met. The research isn’t done.
The second is post-hoc storytelling. A team that did pick ambitious KRs reaches the end of the quarter, realizes they didn’t hit the target, and starts negotiating with themselves. The KR said “reduce mean detection time by 40%.” They reduced it by 9%. The narrative becomes “we learned a lot about why 40% was unrealistic and the work positions us well for next quarter.” That’s a 0.7, isn’t it? The framework wasn’t built to push back on that.
Both failure modes look like the team is bad at OKRs. They aren’t. OKRs for R&D teams break here because the system is asking the wrong question of the work.
What Should OKRs for R&D Teams Actually Measure?
The cleanest reframe is to separate work into two buckets and write KRs to fit each.
Delivery work has a known target. Ship the migration, hit the latency number, close the audit. You can score against the result because the result is the point. If the number didn’t move, the KR wasn’t met.
Research work doesn’t have a known target. The reason you’re doing the work is that you don’t know what you’ll find. You can’t honestly commit to “reduce breach detection time by 40%” if the entire point of the quarter is finding out whether reducing it that far is even possible.
So you score the inquiry, not the answer.
For delivery KRs, the question is: did the outcome happen?
For research KRs, the question is: did we run the inquiry well enough that the org can act on what we found?
Both are honest. Both are scoreable. They just need different rubrics.
How to Write OKRs for R&D Teams Around Unknown Outcomes
A research-shaped KR has three properties.
- It anchors on the question, not the answer. Instead of committing to a result that may or may not be possible, the KR commits to testing the hypothesis. “Test whether adaptive deception can reduce mean detection time by 50% in a controlled environment” beats “reduce mean detection time by 50%” when nobody knows yet whether 50% is achievable.
- It defines what a decision-quality answer looks like. The KR has to specify what counts as a result the org can act on. A binary yes / no / not yet, with evidence, is decision-quality. A “we sort of looked at it” is not. Build the standard into the KR itself: “produce a written recommendation, with supporting evidence, on whether to invest further or kill the line.”
- It includes the share. Research that lives on one team’s hard drive doesn’t help the org. The KR should require that the finding makes it into a form the rest of the org can use. Internal whitepaper, decision memo, technical brief to the leadership team, code committed to a shared repo. Pick one and put it in the KR.
Under this rubric, a well-run experiment that proves something doesn’t work scores a 1.0, because the org now knows where not to invest. A “successful” experiment with sloppy methodology that nobody can build on scores 0.3, because no one can trust the answer.
That inversion is the whole game. Research teams come into OKR rollouts trained to feel like a failed hypothesis is a failed quarter. The right scoring rubric makes a clear “no, here’s why” worth as much as a clear “yes, here’s why.”
Outcome-Shaped vs Research-Shaped KRs
| Activity-shaped (weak) | Outcome-shaped (delivery) | Research-shaped (exploration) |
|---|---|---|
| Run 12 experiments on adaptive deception | Reduce breach detection time from 14 min to 8 min | Test the deception-vs-detection hypothesis and produce a decision-quality recommendation by Q3 end |
| Publish 3 whitepapers on PQC migration | 100% of customer-facing services migrated to PQC by Q4 | Identify the 3 PQC migration paths most viable for our network architecture, with risk assessment, by Q3 end |
| Run 5 biometric authentication trials | Lift continuous-auth accuracy from 91% to 96% on production traffic | Determine whether continuous biometric auth can hold above 95% accuracy under our session-load profile, with a kill / proceed recommendation |
| Investigate adaptive micro-segmentation | Cut lateral movement blast radius by 60% in red-team exercises | Produce an evidence-based answer on whether adaptive micro-segmentation can be deployed without breaking existing app dependencies |
Notice what the research-shaped column shares. Every KR commits to producing a decision, not a result. The team isn’t on the hook for the answer being yes. They’re on the hook for the answer being clear.
Scoring OKRs for R&D Teams Without Killing Exploration
End-of-cycle scoring for research KRs should run through four questions, in order.
- Did the team actually test the hypothesis they committed to test?
- Did they produce a decision-quality answer (clear yes, clear no, or “not yet, and here’s specifically what we’d need”)?
- Is the methodology defensible enough that the org can act on it?
- Did the finding make it into a shareable form?
Four yeses is a 1.0, regardless of whether the answer was the one anyone hoped for. Three yeses is roughly a 0.7. Two or fewer is a signal to pause and ask whether the work should continue.
This rubric punishes the right things. Vague methodology drops your score. Findings that nobody can find next quarter drop your score. A team that ran a clean experiment, found the idea doesn’t work, and wrote it up well gets full credit, because they saved the org from spending another two quarters on a dead end.
For a deeper walkthrough of 0-to-1 scoring mechanics and how Commit / Target / Stretch frame the targets, the OKR Scoring Guide covers the foundations. For the most rigorous public treatment of OKR scoring methodology outside our own work, Ben Lamorte’s writing at okrs.com is worth the time.
What About Teams Doing Both Research and Delivery?
Most R&D teams have a mixed portfolio. A cybersecurity research centre might be running PQC migration (delivery-shaped, the endpoint is known) and adaptive deception research (research-shaped, the endpoint is unknown) in the same quarter. Same team. Same OKR cycle. OKRs for R&D teams have to handle both without forcing one to look like the other.
The answer isn’t to pick one rubric and force-fit everything. It’s to let each KR carry its own type. Label them. Score them differently. The Objective is still one statement of what the team is trying to accomplish; the KRs underneath it can mix delivery-shaped and research-shaped depending on what the work actually is.
What you can’t do is write the Objective itself in a way that pretends the research is delivery. “Ship adaptive deception capability in Q3” is a lie if you haven’t yet proven the capability is achievable. The Objective has to be honest about the mix: “Advance our deception-security portfolio through validated research and shipped capability.”
Then the KRs do the heavy lifting of telling everyone what’s being measured how.
FAQ: OKRs for R&D Teams
Can OKRs work for pure research teams that aren’t shipping anything?
Yes, but only if the KRs are written to measure inquiry quality, not output quantity. The most common mistake is treating “number of papers published” or “number of experiments run” as the KR. Those are activity-shaped and gameable. A research-shaped KR commits to producing a decision-quality answer to a specific question, scored on whether the answer is clear and defensible, not on whether it’s the answer anyone wanted. Innovation measurement has been studied for decades by groups like MIT Sloan Management Review and the lesson keeps repeating: when exploratory work is measured the same way as operational work, the exploration quietly disappears.
How do you stop a team from gaming research OKRs?
The two most common gaming patterns are picking safe hypotheses (so the answer is obvious before the work starts) and retrofitting the scoring (so a 9% improvement becomes a 0.7 narrative). Both go away when the KR commits to a clearly stated hypothesis upfront and the scoring rubric explicitly credits clear “no, here’s why” answers as 1.0s. Gaming the system only works when the system rewards ambiguity. Cut the ambiguity.
Should R&D teams use stretch OKRs the way Google does?
Carefully. Google’s stretch model assumes you have enough independent shots on goal that some will pay off. Smaller R&D teams rarely have that kind of portfolio depth, especially in mid-market companies. Stretch OKRs in a small research team can lead to nothing shipping for two quarters in a row. A better default is a clear hypothesis, a clear standard for what the answer needs to look like, and honest scoring on whether the team delivered the inquiry, not the outcome.
How often should R&D teams check in on OKRs?
OKRs for R&D teams have the same cadence as delivery teams. Weekly. The check-in question changes, though. Delivery teams ask “from what, to what?” on the outcome metric (last week’s value to this week’s, the delta the team owns). Research teams ask “what did we learn this week, and does it change our hypothesis or our methodology?” A weekly cadence catches research that’s drifting toward a dead end early, before the team burns a full quarter on it.
OKR Scoring Guide: Free Download
If your team is rolling out OKRs across mixed work types, research and delivery in the same portfolio, the scoring methodology has to be locked in before the cycle starts, not negotiated at the end. The OKR Scoring Guide walks through 0-to-1 scoring, Commit / Target / Stretch targets, and end-of-cycle retrospectives that hold up under both rubrics.
The R&D function exists because somebody decided it was worth funding work whose outcome can’t be known in advance. OKRs for R&D teams have to honor that, or the framework stops being a goal-setting tool and starts being a way to punish the team for doing the job they were hired to do. Write the KRs to fit the work. Score the inquiry, not the answer. The exploration will survive.
